12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients
Status:
Completed
Trial end date:
2016-03-23
Target enrollment:
Participant gender:
Summary
This study was designed to evaluate the renal function comparing Certican based
immunosuppressive regimens with two different CNIs (Tacrolimus or Cyclosporin A) versus a
standard treatment with Mycophenolic Acid and Tacrolimus in de novo renal transplant
recipients.